enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Mirvetuximab soravtansine - Wikipedia

    en.wikipedia.org/wiki/Mirvetuximab_soravtansine

    Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.

  3. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  4. Tafasitamab - Wikipedia

    en.wikipedia.org/wiki/Tafasitamab

    Tafasitamab, in combination with lenalidomide, is indicated for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). [5]In the EU, minjuvi is indicated in combination with lenalidomide followed by tafasitamab monotherapy for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma who are not eligible for autologous stem cell ...

  5. FDA approves new drug that may help stop a rare, fatal ... - AOL

    www.aol.com/news/fda-approves-drug-may-help...

    For premium support please call: 800-290-4726 more ways to reach us

  6. What does growth hormone therapy treat? What an ... - AOL

    www.aol.com/does-growth-hormone-therapy-treat...

    In adults, GH therapy has been FDA-approved to treat GHD and HIV-related muscle loss. What causes growth hormone deficiency? GHD is a relatively rare condition. Slowed growth, short stature, and ...

  7. FDA approves weight-loss drug to treat sleep apnea - AOL

    www.aol.com/fda-approves-weight-loss-drug...

    The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

  8. Capivasertib - Wikipedia

    en.wikipedia.org/wiki/Capivasertib

    Capivasertib, sold under the brand name Truqap, is an anti-cancer medication used for the treatment of breast cancer. [4] [7] It is taken by mouth.[4]The most common adverse reactions include diarrhea, cutaneous adverse reactions, increased random glucose, decreased lymphocytes, decreased hemoglobin, increased fasting glucose, nausea, fatigue, decreased leukocytes, increased triglycerides ...

  9. What is Compounded Tirzepatide? Here's What You Need to Know

    www.aol.com/compounded-tirzepatide-heres-know...

    It’s FDA-approved to help people with type 2 diabetes manage their blood sugar levels. It’s also often prescribed off-label for weight loss. It’s also often prescribed off-label for weight loss.